| UBE2N |
UBE2N, BLU: Ubiquitin-conjugating enzyme E2 N |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
13.400 |
Evidence |
|
| VCPIP1 |
VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
13.360 |
Evidence |
|
| E2F1 |
E2F1, RBBP3: Transcription factor E2F1 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
13.360 |
Evidence |
|
| HMGA2 |
HMGA2, HMGIC: High mobility group protein HMGI-C |
HDAC2 |
HDAC2: Histone deacetylase 2 |
13.360 |
Evidence |
|
| MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
13.360 |
Evidence |
|
| HIVEP1 |
IPI00013444 |
CCNB1 |
Cyclin B1 |
13.360 |
Evidence |
|
| ETS2 |
ETS2: Protein C-ets-2 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
13.360 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
13.360 |
Evidence |
O
|
| RB1 |
RB1: Retinoblastoma-associated protein |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
13.360 |
Evidence |
|
| IPO7 |
IPO7: Uncharacterized protein IPO7 |
COPA |
COPA: Coatomer subunit alpha |
13.360 |
Evidence |
|
| RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
TSPYL2 |
TSPYL2, CDA1, HRIHFB2216, DENTT, TSPX: Testis-specific Y-encoded-like protein 2 |
13.360 |
Evidence |
|
| XPO1 |
XPO1, CRM1: Exportin-1 |
PLEKHA5 |
PLEKHA5, KIAA1686, PEPP2: Pleckstrin homology domain-containing family A member |
13.360 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
SPTA1 |
SPTA1, SPTA: Spectrin alpha chain, erythrocyte |
13.360 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
JUND |
JUND: Transcription factor jun-D |
13.330 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
GP5 |
GP5: Platelet glycoprotein V precursor |
13.320 |
Evidence |
|
| PSMD4 |
PSMD4, MCB1: 26S proteasome non-ATPase regulatory subunit 4 |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
13.290 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
13.290 |
Evidence |
|
| MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
13.290 |
Evidence |
|
| BTAF1 |
BTAF1, TAF172: TATA-binding protein-associated factor 172 |
ARPC1B |
ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B |
13.290 |
Evidence |
|
| RHOG |
RHOG, ARHG: Rho-related GTP-binding protein RhoG precursor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
13.270 |
Evidence |
|
| ARHGDIA |
ARHGDIA, GDIA1: Rho GDP-dissociation inhibitor 1 |
RAC3 |
RAC3: Ras-related C3 botulinum toxin substrate 3 precursor |
13.270 |
Evidence |
O
|
| PAK4 |
PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 |
RAC3 |
RAC3: Ras-related C3 botulinum toxin substrate 3 precursor |
13.270 |
Evidence |
|
| SPTBN2 |
SPTBN2, KIAA0302: Spectrin beta chain, brain 2 |
ACTR1B |
ACTR1B, CTRN2: Beta-centractin |
13.270 |
Evidence |
|
| EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
EFNB3 |
EFNB3, EPLG8, LERK8: Ephrin-B3 precursor |
13.270 |
Evidence |
|
| EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
EPHB6 |
EPHB6: Ephrin type-B receptor 6 precursor |
13.270 |
Evidence |
O
|
-